Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues

Epigenomics

Volumn 3, Issue 1, 2011, Pages 111-124

  Seelan, Ratnam S ^a,b,c   Pisano, M Michele ^a   Greene, Robert M ^a   Casanova, Manuel F ^b   Parthasarathy, Ranga N ^a,b,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CpG island; CpG methylation; epigenetics; Isyna1; mean methylation index; myo inositol; myo inositol 3 phosphate synthase; T DMR; tissue specific differentially methylated region

Indexed keywords

DNA; GENOMIC DNA; INOSITOL; MESSENGER RNA; MYOINOSITOL 1 PHOSPHATE SYNTHASE; MYOINOSITOL 3 PHOSPHATE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; IN VITRO STUDY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; SEX DIFFERENCE; SOUTHERN BLOTTING; SPLEEN; TESTIS; TISSUE SPECIFICITY;

ANIMALS; BLOTTING, SOUTHERN; BRAIN; CELL LINE; CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; INOSITOL PHOSPHATES; INTRAMOLECULAR LYASES; MALE; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SULFITES; TRANSFECTION;

RATTUS;

EID: 79951907634     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.73     Document Type: Article

References (45)

1. Maeda T, Eisenberg F Jr: Purification, structure, and catalytic properties of l-myo- inositol 1-phosphate synthase from rat testis. J. Biol. Chem. 255, 8458-8464 (1980).
2. Seelan RS, Lakshmanan J, Casanova MF, Parthasarathy RN: Identification of myo- inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa gc isoform. J. Biol. Chem. 284, 9443-9457 (2009).
3. Shamir A, Shaltiel G, Mark S, Bersudsky Y, Belmaker RH, Agam G: Human MIP synthase splice variants in bipolar disorder. Bipolar Disord. 9, 766-771 (2007). (Pubitemid 350042413)
4. Harwood AJ: Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117-126 (2005). (Pubitemid 40139592)
5. Delmas P, Coste B, Gamper N, Shapiro MS: Phosphoinositide lipid second messengers: new paradigms for calcium channel modulation. Neuron 47, 179-182 (2005). (Pubitemid 41019249)
6. Andreassi C, Zimmermann C, Mitter R et al.: An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons. Nat. Neurosci. 13, 291-301 (2010).
7. Cosker KE, Segal RA: The longer U(T)R, the further you go. Nat. Neurosci. 13, 273-275 (2010).
8. Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, Zang FC: Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement. Geriatr. Cogn. Disord. 28, 558-566 (2009).
9. Yücel M, Wood SJ, Wellard RM et al.: Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust. NZ J. Psychiatry 42, 467-477 (2008). (Pubitemid 351891125)
10. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS: A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 146, 137-147 (2006).
11. Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR: Gray and white matter brain chemistry in young children with autism. Arch. Gen. Psychiatry 63, 786-794 (2006).
12. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry 154, 1148-1150 (1997). (Pubitemid 27328834)
13. Mader I, Rauer S, Gall P, Klose U: (1)H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur. J. Radiol. 67, 250-257 (2008).
14. Beacher F, Simmons A, Daly E et al.: Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry 62, 1360-1365 (2005). (Pubitemid 41746613)
15. Copp AJ, Greene ND: Genetics and development of neural tube defects. J. Pathol. 220, 217-230 (2010).
16. Harris MJ, Juriloff DM: Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 79, 187-210 (2007). (Pubitemid 46411279)
17. Palatnik A, Frolov K, Fux M, Benjamin J: Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J. Clin. Psychopharmacol. 21, 335-339 (2001). (Pubitemid 32452940)
18. Vaden DL, Ding D, Peterson B, Greenberg ML: Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J. Biol. Chem. 276, 15466-15471 (2001).
19. Levine J, Barak Y, Gonzalves M et al.: Double-blind, controlled trial of inositol treatment of depression. Am. J. Psychiatry 152, 792-794 (1995).
20. Seelan RS, Parthasarathy LP, Parthasarathy RN: E2F1 regulation of the human myo-inositol 1-phosphate synthase (ISYNA1) gene promoter. Arch. Biochem. Biophys. 431, 95-106 (2004). (Pubitemid 39349362)
21. Takaya T, Kasatani K, Noguchi S, Nikawa J: Functional analyses of immediate early gene ETR101 expressed in yeast. Biosci. Biotechnol. Biochem. 73, 1653-1660 (2009).
22. Malo MS, Abedrapo M, Chen A, Mozumder M et al.: Improved eukaryotic promoter-detection vector carrying two luciferase reporter genes. Biotechniques 35, 1150-1154 (2003). (Pubitemid 37517491)
23. Tusnady GE, Simon I, Varadi A, Aranyi T: BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes. Nucleic Acids Res. 33, e9 (2005).
24. Guerrero-Bosagna C, Settles M, Lucker B, Skinner MK: Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome. PLoS ONE 5(9), pii e13100 (2010).
25. Grunau, C, Clark SJ, Rosenthal, A: Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 29, e65 (2001).
26. Lister R, Pelizzola M, Dowen RH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322 (2009).
27. Marcourt L, Cordier C, Couesnon T, Dodin G: Impact of C5-cytosine methylation on the solution structure of d(GAAAACGTTTTC)2: an NMR and molecular modelling investigation. Eur. J. Biochem. 265, 1032-1042 (1999). (Pubitemid 29507817)
28. Bakker J, De Mees C, Douhard Q et al.: a-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat. Neurosci. 9, 220-226 (2006). (Pubitemid 43164545)
29. Guan G, Dai P, Shechter I: cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase. Arch. Biochem. Biophys. 417, 251-259 (2003). (Pubitemid 36993802)
30. Schmidl C, Klug M, Boeld TJ et al.: Lineage- specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res. 19, 1165-1174 (2009).
31. Laurent L, Wong E, Li G et al.: Dynamic changes in the human methylome during differentiation. Genome Res. 20, 320-331 (2010).
32. Ball MP, Li JB, Gao Y et al.: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27, 361-368 (2009). Erratum: 27, 485.
33. Cahill L: Why sex matters for neuroscience. Nat. Rev. Neurosci. 7, 477-484 (2006). (Pubitemid 44012287)
34. Mitka M: Rising autism rates still pose a mystery. JAMA 303, 602 (2010).
35. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for Disease Control and Prevention: Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill. Summ. 58, 1-20 (2009).
36. Hasin DS, Stinson FS, Ogburn E, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 64, 830-842 (2007). (Pubitemid 47026379)
37. Raine A, Yang Y, Narr KL, Toga AW: Sex differences in orbitofrontal gray as a partial explanation for sex differences in antisocial personality. Mol. Psychiatry 16(2), 227-236 (2011).
38. Sassi RB: Attention-deficit hyperactivity disorder and gender. Arch. Womens Ment. Health 13, 29-31 (2010).
39. Støving RK, Andries A, Brixen K, Bilenberg N, Hørder K: Gender differences in outcome of eating disorders: a retrospective cohort study. Psychiatry Res. (2010) (Epub ahead of print).
40. Kessler RC, Berglund P, Demler O et al.: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095-3105 (2003). (Pubitemid 37432885)
41. Brahmachari S, Pahan K: Gender-specific expression of b1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis. J. Immunol. 184, 6103-6113 (2010).
42. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 63, 415-424 (2006).
43. Lilly MM, Pole N, Best SR, Metzler T, Marmar CR: Gender and PTSD: what can we learn from female police officers? J. Anxiety Disord. 23, 767-774 (2009).
44. Kurian JR, Olesen KM, Auger AP: Sex differences in epigenetic regulation of the estrogen receptor-a promoter within the developing preoptic area. Endocrinology 151, 2297-2305 (2010).
45. Irizarry RA, Ladd-Acosta C, Wen B et al.: The human colon cancer methylome shows similar hypo and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186 (2009).